Affiliation:
1. Division of Infectious Diseases Duke University Medical Center Durham North Carolina USA
2. Center for Social and Behavioral Research University of Northern Iowa Cedar Falls Iowa USA
3. School of Medicine University of South Carolina Columbia South Carolina USA
4. Division of Infectious Diseases University of South Carolina, Prisma Health‐Midlands Columbia South Carolina USA
5. Duke Initiative on Survey Methodology Duke University Durham North Carolina USA
6. Kennedy Pharmacy Innovation Center University of South Carolina Columbia South Carolina USA
7. Department of Population Health Sciences Duke University Durham North Carolina USA
8. Duke Clinical Research Institute Duke University Durham North Carolina USA
Abstract
AbstractIntroductionHuman immunodeficiency virus (HIV) pre‐exposure prophylaxis (PrEP) is largely underutilized in the Southern United States. Given their community presence, pharmacists are well positioned to provide PrEP within rural, Southern regions. However, pharmacists' readiness to prescribe PrEP in these communities remains unknown.ObjectiveTo determine the perceived feasibility and acceptability of prescribing PrEP by pharmacists in South Carolina (SC).MethodsWe distributed a 43‐question online descriptive survey through the University of South Carolina Kennedy Pharmacy Innovation Center's listserv of licensed SC pharmacists. We assessed pharmacists' comfort, knowledge, and readiness to provide PrEP.ResultsA total of 150 pharmacists responded to the survey. The majority were White (73%, n = 110), female (62%, n = 93), and non‐Hispanic (83%, n = 125). Pharmacists practiced in retail (25%, n = 37), hospital (22%, n = 33), independent (17%, n = 25), community (13%, n = 19), specialty (6%, n = 9), and academic settings (3%, n = 4); 11% (n = 17) practiced in rural locales. Pharmacists viewed PrEP as both effective (97%, n = 122/125) and beneficial (74% n = 97/131) for their clients. Many pharmacists reported being ready (60% n = 79/130) and willing (86% n = 111/129) to prescribe PrEP, although over half (62% n = 73/118) cited lack of PrEP knowledge as a barrier. Pharmacists described pharmacies as an appropriate location to prescribe PrEP (72% n = 97/134).ConclusionsMost SC pharmacists surveyed considered PrEP to be effective and beneficial for individuals who frequent their pharmacy and are willing to prescribe this therapy if statewide statutes allow. Many felt that pharmacies are an appropriate location to prescribe PrEP but lack a complete understanding of required protocols to manage these patients. Further investigation into facilitators and barriers of pharmacy‐driven PrEP is needed to enhance utilization within communities.
Funder
Center for AIDS Research, Duke University
National Institute of Allergy and Infectious Diseases
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacy
Reference50 articles.
1. Centers for Disease Control and Prevention. Diagnosis of HIV Infection in the United States and dependent areas.CDC HIV Surveillance Report.29.2017[cited 2019 May 12] Available from:https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc‐hiv‐surveillance‐report‐2017‐vol‐29.pdf.
2. US Department of Health and Human Services.Ending the HIV epidemic: about ending the HIV epidemic in the US: overview. [cited 2021 July 30] Available from:https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview
3. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States
4. US Department of Health and Human Services.Ending the HIV epidemic: about ending the HIV epidemic in the US: priority jurisdictions: phase I. [cited 2021 July 30] Available from:https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/jurisdictions/phase-one
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献